Notfälle
Blutspende
Karriere
Presse
Forschung
Lehre
Patienten
Zuweiser

Porten E, Seliger B, Schneider VA, Wöll S, Stangel D, Ramseger R, Kröger S. The process-inducing activity of transmembrane agrin requires follistatin-like domains. J Biol Chem 2010; 285:3114-25.

 

Seliger B, Stoehr R, Handke M, Mueller A, Ferrone S, Wullich B, Tannapfel A, Hofsteadter F, Hartmann A. Association of HLA class I antigen abnormalities with disease progression and early recurrence in prostate cancer. Cancer Immunol Immunother. 2010; 59:529-40.

 

Seliger B, Massa C, Rini B, Ko J and Finke J. Antitumour and immune-adjuvant activities of protein-tyrosine kinase inhibitors. Trends Mol Med. 2010; 16:184-92.

 

Kamphausen E, Kellert C, Abbas T, Akkad N, Tenzer S, Pawelec G, Schild H, van Endert P, Seliger B. Distinct molecular mechanisms leading to deficient expression of ER-resident aminopeptidases in melanoma. Cancer Immunol Immunother. 2010; 59:1273-84.